There is not previous report about the seroepidemiology of Toxoplasma gondii infection in the central Mexican state of San Luis Potosí. Therefore, we aimed to determine the prevalence of T. gondii infection and the sociodemographic, clinical, behavioral, and housing characteristics associated with this infection in the general population in Matehuala City, San Luis Potosí.This cross-sectional study was performed from January to April 2018. In total, 636 subjects (mean age: 36.95±17.67 years; range: 18–91 years) were included. Anti-T. gondii IgG antibodies were detected using a commercially available enzyme immunoassay “T. gondii IgG” kit (Diagnostic Automation/Cortez Diagnostics, Inc., Woodland Hills, California. USA). All sera with seroreactivity to T. gondii IgG were further tested for anti-T. gondii IgM antibodies by a commercially available enzyme immunoassay “T. gondii IgM” kit (Diagnostic Automation/Cortez Diagnostics, Inc.).This study was approved by the Institutional Ethical Committee of the General Hospital of the Health Services in Matehuala City, Mexico.Of the 636 subjects studied, 54 (8.5%) were positive for anti-T. gondii IgG antibodies. Twenty-two (40.7%) of these subjects positive for anti-T. gondii IgG antibodies were also positive for anti-T. gondii IgM antibodies.In a search in the medical literature about studies of seroprevalence in urban general population in Mexico, only one previous study was found. In that study, a 6.1% seroprevalence of T. gondii infection in general population in the northern Mexican city of Durango was found (1). This seroprevalence is comparable to the one found in our present study. On the other hand, in an international context, the seroprevalence found in the general population in Matehuala was lower than seroprevalences in the general populations reported in Portugal (22%) (2), Italy (24.4%) (3), Netherlands (26.0%) (4), and Iran (39.3%) (5). It is not clear why the seroprevalence of T. gondii infection in general population in Matehuala is lower than those reported in general populations in other countries. It is likely that differences in the characteristics of the populations studied and in the environment among countries may explain the differences in the rate of T. gondii infection.In the current study, we searched for risk factors associated with T. gondii seropositivity. Logistic regression showed that T. gondii infection was positively associated with consumption of goat meat (OR = 1.81; 95% CI: 1.01–3.24; P=0.04), and negatively associated with ham consumption (OR = 0.44; 95% CI: 0.21–0.94; P=0.03). Other sociodemographic, clinical, behavioral, and housing characteristics were not associated with T. gondii infection. Consumption of goat meat has been associated with T. gondii seropositivity in Mexico. In a study of patients suffering from epilepsy in Durango City, a positive association between T. gondii seropositivity and consumption of goat meat was found (6). On the other hand, the negative association between T. gondii seropositivity and ham consumption found in this study suggests that ham consumption was not an important contributing factor for infection in the population studied.In this first study about the epidemiology of T. gondii infection in San Luis Potosí, Mexico, we reported a low seroprevalence of this infection in the general population in Matehuala City. Consumption of goat meat was an important factor associated with T. gondii infection in the population studied. Results may help in the design of optimal preventive measures against T. gondii infection.
Authors: C Alvarado-Esquivel; S Estrada-Martínez; H Pizarro-Villalobos; M Arce-Quiñones; O Liesenfeld; J P Dubey Journal: J Parasitol Date: 2010-09-03 Impact factor: 1.276
Authors: A Hofhuis; W van Pelt; Y T H P van Duynhoven; C D M Nijhuis; L Mollema; F R M van der Klis; A H Havelaar; L M Kortbeek Journal: Epidemiol Infect Date: 2010-05-24 Impact factor: 2.451
Authors: Maria João Gargaté; Idalina Ferreira; Anabela Vilares; Susana Martins; Carlos Cardoso; Susana Silva; Baltazar Nunes; João Paulo Gomes Journal: BMJ Open Date: 2016-10-05 Impact factor: 2.692
Authors: Cosme Alvarado-Esquivel; Yazmin Del Rosario Rico-Almochantaf; Jesús Hernández-Tinoco; Gerardo Quiñones-Canales; Luis Francisco Sánchez-Anguiano; Jorge Torres-González; Eda Guadalupe Ramírez-Valles; Andrea Minjarez-Veloz Journal: SAGE Open Med Date: 2018-04-10